Balyasny Asset Management L.P. Sells 2,558,478 Shares of Healthpeak Properties, Inc. (NYSE:DOC)

Balyasny Asset Management L.P. trimmed its position in Healthpeak Properties, Inc. (NYSE:DOC) by 98.4% in the 4th quarter, HoldingsChannel reports. The fund owned 42,244 shares of the real estate investment trust’s stock after selling 2,558,478 shares during the quarter. Balyasny Asset Management L.P.’s holdings in Healthpeak Properties were worth $856,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Mizuho Bank Ltd. purchased a new stake in Healthpeak Properties in the 4th quarter worth approximately $28,000. Harvest Fund Management Co. Ltd purchased a new stake in Healthpeak Properties in the 4th quarter worth approximately $30,000. Covestor Ltd increased its holdings in Healthpeak Properties by 173.8% in the 4th quarter. Covestor Ltd now owns 1,815 shares of the real estate investment trust’s stock worth $37,000 after acquiring an additional 1,152 shares in the last quarter. AdvisorNet Financial Inc increased its holdings in Healthpeak Properties by 34.5% in the 4th quarter. AdvisorNet Financial Inc now owns 2,193 shares of the real estate investment trust’s stock worth $44,000 after acquiring an additional 563 shares in the last quarter. Finally, Kestra Investment Management LLC purchased a new stake in Healthpeak Properties in the 4th quarter worth approximately $45,000. 93.57% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on DOC shares. StockNews.com lowered shares of Healthpeak Properties from a “hold” rating to a “sell” rating in a report on Thursday, May 1st. Robert W. Baird reduced their target price on shares of Healthpeak Properties from $24.00 to $22.00 and set an “outperform” rating for the company in a report on Tuesday, April 29th. Wedbush dropped their price target on Healthpeak Properties from $24.00 to $22.00 and set an “outperform” rating for the company in a research note on Monday, April 28th. Argus restated a “buy” rating and issued a $25.00 price target on shares of Healthpeak Properties in a research note on Tuesday, April 29th. Finally, Morgan Stanley upgraded Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 price target for the company in a research note on Wednesday, January 15th. One analyst has rated the stock with a sell rating, three have given a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $23.25.

Insider Activity

In related news, CEO Scott M. Brinker purchased 2,750 shares of the stock in a transaction that occurred on Friday, May 9th. The stock was bought at an average cost of $17.39 per share, for a total transaction of $47,822.50. Following the completion of the transaction, the chief executive officer now directly owns 204,613 shares in the company, valued at $3,558,220.07. This represents a 1.36% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director John T. Thomas purchased 4,200 shares of the stock in a transaction that occurred on Monday, April 28th. The stock was bought at an average price of $17.84 per share, with a total value of $74,928.00. Following the completion of the transaction, the director now owns 813,566 shares of the company’s stock, valued at $14,514,017.44. The trade was a 0.52% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last ninety days, insiders bought 23,987 shares of company stock worth $422,141. 0.23% of the stock is currently owned by insiders.

Healthpeak Properties Stock Down 1.5%

NYSE DOC opened at $16.99 on Thursday. The company has a debt-to-equity ratio of 0.96, a quick ratio of 1.35 and a current ratio of 1.35. The company has a market capitalization of $11.80 billion, a P/E ratio of 48.54, a P/E/G ratio of 2.17 and a beta of 1.05. Healthpeak Properties, Inc. has a one year low of $16.90 and a one year high of $23.26. The stock has a 50 day moving average price of $18.97 and a 200-day moving average price of $20.17.

Healthpeak Properties (NYSE:DOC) last posted its earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 EPS for the quarter, meeting analysts’ consensus estimates of $0.46. The firm had revenue of $702.89 million during the quarter, compared to the consensus estimate of $690.76 million. Healthpeak Properties had a return on equity of 2.61% and a net margin of 9.00%. The company’s quarterly revenue was up 15.9% compared to the same quarter last year. During the same period in the prior year, the company earned $0.45 EPS. As a group, equities analysts predict that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Dividend Announcement

The company also recently announced a dividend, which was paid on Wednesday, April 30th. Stockholders of record on Friday, April 18th were given a dividend of $0.1017 per share. The ex-dividend date was Thursday, April 17th. This represents a dividend yield of 6.5%. Healthpeak Properties’s dividend payout ratio is currently 305.00%.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.